Cas3 has been previously tested by Morisaka et al. (2019) in an exon-skipping strategy using Duchenne muscular dystrophy (DMD)-induced pluripotent stem cells (iPSCs) [34]. This evidence concerns the gene EFS and Duchenne muscular dystrophy.